KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa.
Resource Type
CF Research News
Authors
References
J Cyst Fibros. 2017 Dec 29. pii: S1569-1993(17)30984-0. doi: 10.1016/j.jcf.2017.12.006
Document
Link
Date
Friday, December 29, 2017
Featured resource article
Yes
Resource - Guideline Type
Other Guidelines [3]